LCAT Antikörper (Internal Region)
-
- Target Alle LCAT Antikörper anzeigen
- LCAT (Lecithin-Cholesterol Acyltransferase (LCAT))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LCAT Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- LCAT
- Sequenz
- PYDWRLEPGQ
- Kreuzreaktivität
- Human
- Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Güteklasse
- Verified
- Isotyp
- IgG
- Top Product
- Discover our top product LCAT Primärantikörper
-
anti-Lecithin-Cholesterol Acyltransferase (LCAT) (AA 290-433) antibody
LCAT Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Lecithin-Cholesterol Acyltransferase (LCAT) (AA 290-432) antibodyLCAT Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Lecithin-Cholesterol Acyltransferase (LCAT) (AA 41-210) antibodyLCAT Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Lecithin-Cholesterol Acyltransferase (LCAT) (AA 285-313) antibodyLCAT Reaktivität: Human WB, IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB23365 unconjugated
anti-Lecithin-Cholesterol Acyltransferase (LCAT) (C-Term) antibodyLCAT Reaktivität: Human, Maus, Ratte, Hund, Rind (Kuh), Kaninchen, Meerschweinchen, Schaf, Pferd, Zebrafisch (Danio rerio) WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Lecithin-Cholesterol Acyltransferase (LCAT) (AA 41-210) antibodyLCAT Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Lecithin-Cholesterol Acyltransferase (LCAT) (AA 290-433) antibodyLCAT Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal 12# unconjugated
anti-Lecithin-Cholesterol Acyltransferase (LCAT) (AA 151-250) antibodyLCAT Reaktivität: Human, Maus, Ratte WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Lecithin-Cholesterol Acyltransferase (LCAT) (AA 98-197) antibodyLCAT Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 4A9 unconjugated
anti-Lecithin-Cholesterol Acyltransferase (LCAT) (AA 292-321), (Middle Region) antibodyLCAT Reaktivität: Human WB, IF, FACS, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Western Blot: Approx 55 kDa band observed in Human Testis lysates (calculated MW of 49.6 kDa according to NP_000220.1). This molecular weight is routinely observed by other sources. Recommended concentration: 0.3-1 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:64000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Target
- LCAT (Lecithin-Cholesterol Acyltransferase (LCAT))
- Andere Bezeichnung
- LCAT (LCAT Produkte)
- Synonyme
- AI046659 antikoerper, D8Wsu61e antikoerper, MGC82035 antikoerper, lcat antikoerper, MGC88964 antikoerper, LCAT antikoerper, lecithin-cholesterol acyltransferase antikoerper, lecithin cholesterol acyltransferase antikoerper, lecithin-cholesterol acyltransferase L homeolog antikoerper, solute carrier family 12 member 4 antikoerper, fragile site, aphidicolin type, common, fra(13)(q13.2) antikoerper, LCAT antikoerper, Lcat antikoerper, lcat.L antikoerper, lcat antikoerper, SLC12A4 antikoerper, FRA13A antikoerper
- Hintergrund
- LCAT, lecithin-cholesterol acyltransferase, phosphatidylcholine-sterol acyltransferase, phospholipid-cholesterol acyltransferase
- Gen-ID
- 3931
- NCBI Accession
- NP_000220
- Pathways
- Lipid Metabolism
-
